Heron Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Heron Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Heron Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Heron Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Heron Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Heron Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Adam Morgan
Chairman Executive BoardMr. Adam Morgan has been the Chairman of the company since April 2023. Currently, he also serves as Director of Alimera Sciences, Inc. Previously, Morgan served as Senior Analyst at Broadfin Capital, LLC from February 2018 to June 2020. Prior to that, he served as Senior Analyst at Iguana Healthcare Partners LLC from 2015 to January 2018. Earlier, he served as an Analyst at Pura Vida Investments, LLC from 2014 to 2015. Mr. Morgan also served as a Research Associate at Cowen and Company from January 2014 to June 2014.
Craig Collard
Chief Executive Officer; Director Executive BoardMr. Craig Collard has been the Chief Executive Officer and Director of the company since 2023. Prior to this, he served as the Chief Executive Officer of Veloxis Pharmaceutics and Chief Executive Officer and Chairman, President and Interim Chief Financial Officer of Cornerstone Therapeutics Inc. Previously, he served as the President and Chief Executive Officer of Cornerstone BioPharma Inc, President and Chief Executive Officer of Carolina Pharmaceuticals, Inc and Vice President of Sales for Verum Pharmaceuticals, Inc.
Ira Duarte
Chief Financial Officer; Executive Vice President Senior ManagementMs. Ira Duarte has been the Executive Vice President and Chief Financial Officer of the company since 2023. Prior to this, she served as the Chief Financial Officer of Veloxis Pharmaceuticals Inc. Previously, she served as the Corporate Controller at BioDelivery Sciences Inc from 2014 to 2016. Ms. Duarte also served as the Senior Director of Corporate Finance for Chiesi USA Inc and Director of Accounting and Financial Planning for Cornerstone Therapeutics Inc.
Mark Hensley
Chief Operating Officer Senior ManagementMr. Mark Hensley has been the Chief Operating Officer of the company since May 2025. Prior to this, he served as the Chief Executive Officer from 2021 to 2024, and Chief Operating Officer and Chief Commercial Officer from 2018 to 2021 at Veloxis Pharmaceuticals, Inc.
William Forbes
Chief Development Officer; Executive Vice President Senior ManagementMr. William Forbes has been the Chief Development Officer and Executive Vice President of the company since 2023. Prior to this, he served as the Chief Development Officer of Trevi Therapeutics Inc and President and Chief Executive Officer of Vivelix Pharmaceuticals Ltd. Previously, he served as the Chief Development Officer of Salix Pharmaceuticals Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer